Guyana — Guyana Environmental Protection Agency & Bayer
7 shared events · Importance 3 · Last updated Jun 26, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Guyana — Guyana Environmental Protection Agency: EPA's determination that glyphosate is not likely carcinogenic and its approval of Roundup's label without a cancer warning were central to the ruling. The agency's authority over pesticide labeling was upheld.
Bayer: Bayer is the primary beneficiary; the ruling shields it from thousands of failure-to-warn lawsuits, reducing litigation risk and boosting investor confidence. Shares rose ~18%.
Jun 25, 2026 · 133 articles
Regulatory
Guyana — Guyana Environmental Protection Agency: The EPA's finding that glyphosate is not likely to cause cancer and its pending updated risk assessment are central to the legal debate over Roundup warning labels.
Bayer: Bayer is the central party seeking court approval of the $7.25 billion settlement to resolve roughly 65,000 Roundup claims; approval would remove a major legal overhang and support its turnaround, while rejection would prolong litigation and weigh on its shares.
Sep 11, 2026 · 6 articles
Business
Bayer: Bayer has agreed to a proposed $7.25 billion settlement to resolve thousands of lawsuits alleging its Roundup weedkiller causes cancer, aiming to reduce litigation uncertainty and financial strain. This settlement is crucial for Bayer's financial survival and ability to continue selling Roundup in agricultural markets.
Feb 17, 2026 · 10 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Guyana — Guyana Environmental Protection Agency and Bayer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard